Clinical Trials Directory

Trials / Completed

CompletedNCT01110863

Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

By ingesting a non-radioactive and non-toxic compound "heavy water" for 6 weeks, the DNA of newly developed cells in the body of subjects with B-cell chronic lymphocytic leukemia can be labeled and followed by performing routine blood draws at specified time intervals. By using mass spectrometric analysis we can measure how quickly new B-CLL cells are generated in the bone marrow and how quickly they leave the blood, a measure of cell turnover. This will help us to better understand the unique characteristics of this disease process.

Detailed description

By ingesting a non-radioactive and non-toxic compound "heavy water" for 6 weeks, the DNA of newly developed cells in the body of subjects with B-cell chronic lymphocytic leukemia (B-CLL) can be labeled and followed by performing routine blood draws at specified time intervals. By using mass spectrometric analysis we can measure how quickly new B-CLL cells are generated in the bone marrow and how quickly they leave the blood, a measure of cell turnover. This will help us to better understand the unique characteristics of this disease process.

Conditions

Timeline

Start date
2005-12-01
Primary completion
2016-02-12
Completion
2016-02-12
First posted
2010-04-27
Last updated
2021-03-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01110863. Inclusion in this directory is not an endorsement.

Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects (NCT01110863) · Clinical Trials Directory